Poulton Stuart
EVP, Chief Development Officer · 9 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Sale | 403 | $9.50 | $3,828.50 | filing |
| 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Award | 896 | $0.00 | $0.00 | filing |
| 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Sale | 5,101 | $9.41 | $47,997.86 | filing |
| 2026-02-17 | KPTI | Karyopharm Therapeutics Inc. | Sale | 378 | $8.63 | $3,262.14 | filing |
| 2026-01-31 | KPTI | Karyopharm Therapeutics Inc. | Award | 32,415 | $0.00 | $0.00 | filing |
| 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Award | 39,682 | $0.00 | $0.00 | filing |
| 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Sale | 401 | $6.43 | $2,578.43 | filing |
| 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Award | 888 | $0.00 | $0.00 | filing |
| 2025-07-29 | KPTI | Karyopharm Therapeutics Inc. | Sale | 191 | $4.37 | $834.67 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.